Shanghai MicroPort MedBot (Group) Co., Ltd (HKG: 2252) announced that its in-house developed orthopedic surgery robot Honghu has received 510(k) certification from the US FDA, marking it as the first and only home-grown surgical robot approved in the US.
Product Highlights
Designed for joint replacement surgery, the Honghu robot offers accurate, efficient, and safe assistance during total knee replacement procedures. Key features include:
- Personalized Surgery Plans: Assists doctors in preoperative planning.
- Reduced Surgical Injuries: Minimizes patient trauma during surgery.
- Improved Postoperative Recovery: Enhances lower limb force line and reduces complications.
The device previously gained market approval in China in April 2024.-Fineline Info & Tech
